• Contact Us: info@helenfoundation.com

Moderate to Severe Multiple Sclerosis: In medical studies, MICRODOSE THERAPY was shown to be clinically effective in about 5 out of 6 adults with multiple sclerosis at 6 weeks. MICRODOSE THERAPY averages 67% average symptom improvement. MICRODOSE THERAPY has been shown to begin working in 1 week with maximum disease control at 6 weeks.